The Global Lichen Planus Market is driven by rising incidences of autoimmune skin diseases
Lichen planus is a common inflammatory skin condition that causes a distinctive purple, itchy rash or lesions on the skin, scalp, nails, mucous membranes, and genitals. It is often the result of an autoimmune response to unknown triggers within the body. Lichen planus most commonly affects middle-aged women and can be accompanied by intense itching and soreness.
The exact cause is unknown, but it is considered an autoimmune disease where the immune system attacks its own tissues. Treatment options for Lichen Planus Market include topical corticosteroids, topical calcineurin inhibitors, phototherapy, and systemic corticosteroids depending on the severity and location of the rash.
The Global Lichen Planus Market is estimated to be valued at USD 150.1 million in 2024 and is expected to reach USD 251.2 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
Get more insights on: Lichen Planus Market
Get this Report in Japanese Language: 扁平苔癬マーケット
Get this Report in Korean Language: 리켄 플라누스 마켓
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian